Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Business Practice

Business in Brief

| Maryam Mahdi

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Business & Regulation Business Practice

How to Commercialize an Orphan Drug

| George A. Chressanthis, Animesh Arun

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Business & Regulation Small Molecules

And for 2020...

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2020 Power List.

Business & Regulation Business Practice

Solutions In... Human Antibodies

| Maryam Mahdi

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

Business & Regulation Business Practice

Business-In-Brief

| Maryam Mahdi

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

Business & Regulation Business Practice

The 2019 Power List

| James Strachan

We are delighted to announce that The Medicine Maker Power List 2019 is here!

Business & Regulation Business Practice

Speak Up!

| Neil Hunter

The evolving Brexit landscape provides ample opportunities for companies to position themselves as leaders and influencers.

Manufacture Business Practice

Scottish Pride and Innovation

| Stephanie Sutton

Sitting Down With… Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre (MMIC), Scotland, UK.

Business & Regulation Standards & Regulation

Tax Credits: Your Work is Worth it

| Peter Beavis

Research and development tax reliefs are available for businesses in many countries, but some companies are not taking advantage.

Business & Regulation Advanced Medicine

Building a Business: Lessons Learned with Angela Osborne

| Maryam Mahdi

Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry bloom.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register